Hui Fang Dong
Science Applications International Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hui Fang Dong.
Journal of Experimental Medicine | 2002
O. M. Zack Howard; Hui Fang Dong; De Yang; Nina Raben; Kanneboyina Nagaraju; Antony Rosen; Livia Casciola-Rosen; Michael Härtlein; Michael A. Kron; David C.H. Yang; Kwabena Yiadom; Sunita Dwivedi; Paul H. Plotz; Joost J. Oppenheim
Autoantibodies to histidyl–tRNA synthetase (HisRS) or to alanyl–, asparaginyl–, glycyl–, isoleucyl–, or threonyl–tRNA synthetase occur in ∼25% of patients with polymyositis or dermatomyositis. We tested the ability of several aminoacyl–tRNA synthetases to induce leukocyte migration. HisRS induced CD4+ and CD8+ lymphocytes, interleukin (IL)-2–activated monocytes, and immature dendritic cells (iDCs) to migrate, but not neutrophils, mature DCs, or unstimulated monocytes. An NH2-terminal domain, 1–48 HisRS, was chemotactic for lymphocytes and activated monocytes, whereas a deletion mutant, HisRS-M, was inactive. HisRS selectively activated CC chemokine receptor (CCR)5-transfected HEK-293 cells, inducing migration by interacting with extracellular domain three. Furthermore, monoclonal anti-CCR5 blocked HisRS-induced chemotaxis and conversely, HisRS blocked anti-CCR5 binding. Asparaginyl–tRNA synthetase induced migration of lymphocytes, activated monocytes, iDCs, and CCR3-transfected HEK-293 cells. Seryl–tRNA synthetase induced migration of CCR3-transfected cells but not iDCs. Nonautoantigenic aspartyl–tRNA and lysyl–tRNA synthetases were not chemotactic. Thus, autoantigenic aminoacyl–tRNA synthetases, perhaps liberated from damaged muscle cells, may perpetuate the development of myositis by recruiting mononuclear cells that induce innate and adaptive immune responses. Therefore, the selection of a self-molecule as a target for an autoantibody response may be a consequence of the proinflammatory properties of the molecule itself.
Journal of Immunology | 2005
Casey A. Carlos; Hui Fang Dong; O. M. Zack Howard; Joost J. Oppenheim; Franz-Georg Hanisch; Olivera J. Finn
The immunostimulatory outcome of the interactions of many pathogens with dendritic cells (DCs) has been well characterized. There are many fewer examples of similar interactions between DCs and self-molecules, especially the abnormal self-proteins such as many tumor Ags, and their effects on DC function and the immune response. We show that human epithelial cell Ag MUC1 mucin is recognized in its aberrantly glycosylated form on tumor cells by immature human myeloid DCs as both a chemoattractant (through its polypeptide core) and a maturation and activation signal (through its carbohydrate moieties). On encounter with MUC1, similar to the encounter with LPS, immature DCs increase cell surface expression of CD80, CD86, CD40, and CD83 molecules and the production of IL-6 and TNF-α cytokines but fail to make IL-12. When these DCs are cocultured with allogeneic CD4+ T cells, they induce production of IL-13 and IL-5 and lower levels of IL-2, thus failing to induce a type 1 response. Our data suggest that, in vivo in cancer patients, MUC1 attracts immature DCs to the tumor through chemotaxis and subverts their function by negatively affecting their ability to stimulate type 1 helper T cell responses important for tumor rejection.
Journal of Leukocyte Biology | 2005
Joost J. Oppenheim; Hui Fang Dong; Paul H. Plotz; Rachel R. Caspi; Michelle Dykstra; Susan K. Pierce; Roland Martin; Casey A. Carlos; Olivera J. Finn; Omanand Koul; O. M. Zack Howard
We have investigated the chemoattractant properties of self‐antigens associated with autoimmune diseases and solid tumors. Many autoantigens induced leukocyte migration, especially by immature dendritic cells (iDC) by interacting with various chemoattractant Gi‐protein‐coupled receptors (GiPCR). Our initial observation that myositis‐associated autoantigens, histidyl‐tRNA synthetase and asparaginyl‐tRNA synthetase, were chemotactic for CC chemokine receptor 5 (CCR5)‐ and CCR3‐expressing leukocytes, while other nonautoantigenic aminoacyl‐tRNA synthesases were not, suggested that only self‐antigens capable of interacting with receptors on antigen‐presenting cells were immunogenic. We next determined that self‐antigens associated with autoimmune diseases, e.g., multiple sclerosis or experimental autoimmune encephalomyelitis, type I diabetes, scleroderma, systemic lupus erythematosus, autoimmune uveitis, or experimental autoimmune uveitis (EAU), were chemotactic for GiPCR expressed by iDC. The majority of autoantigens were DC chemoattractants at 10–100 ng/ml, but did not induce DC maturation until they reached 1000‐fold higher concentrations. Interphotoreceptor retinoid‐binding protein and retinal arrestin (S‐antigen) are targets of autoantibodies in human uveitis and are chemotactic for CXC chemokine receptor 5 (CXCR5)‐ and/or CXCR3‐expressing iDC. However, although S‐antigen does not induce EAU in wild‐type mice, it is nevertheless a chemoattractant for murine iDC. These unexpected observations suggested that the chemotactic activity of these tissue‐specific self‐antigens could be involved in promotion of tissue repair and restoration. Thus, the primary role of autoantigens may be to alert the immune system to danger signals from invaded and damaged tissues to facilitate repair, and autoimmune responses subsequently develop only in subjects with impaired immunoregulatory function.
The Journal of Infectious Diseases | 2006
Bernadette Ramirez; O. M. Zack Howard; Hui Fang Dong; Takeo Edamatsu; Ping Gao; Michael Härtlein; Michael A. Kron
Background. Lymphatic filariasis is a chronic human parasitic disease in which the parasites repeatedly provoke acute and chronic inflammatory reactions in the host bloodstream and lymphatics. Excretory-secretory products derived from filariae are believed to play an important role in the development of associated immunologic conditions; however, the specific mechanisms involved in these changes are not well understood. Recently, human cytoplasmic aminoacyl-transfer (t) RNA synthetases, which are autoantigens in idiopathic inflammatory myopathies, were shown to activate chemokine receptors on T lymphocytes, monocytes, and immature dendritic cells by recruiting immune cells that could induce innate and adaptive immune responses. Filarial (Brugia malayi) asparaginyl-tRNA synthetase (AsnRS) is known to be an immunodominant antigen that induces strong human immunoglobulin G3 responses.Methods. Recombinant B. malayi AsnRS was used to perform cellular function assays--for example, chemotaxis and kinase activation assays.Results. Unlike human AsnRS, parasite AsnRS is chemotactic for neutrophils and eosinophils. Recombinant B. malayi AsnRS but not recombinant human AsnRS induced chemotaxis of CXCR1 and CXCR2 single-receptor-transfected HEK-293 cell lines, blocked CXCL1-induced calcium flux, and induced mitogen-activated protein kinase.Conclusions. Our findings suggest that a filarial parasite chemoattractant protein may contribute to the development of chronic inflammatory disease and that chemokine receptors may be therapeutic targets to ameliorate parasite-induced pathology.
Bioorganic & Medicinal Chemistry Letters | 2001
O. M. Zack Howard; Hui Fang Dong; Joost J. Oppenheim; Shabana Insaf; Kalpathy C. Santhosh; Gitendra Paul; Mark Cushman
The anti-HIV agent cosalane and several of its analogues inhibited RANTES-induced migration of human monocytes, but they did not inhibit migration induced by MIP1alpha or MIP1beta. RANTES-induced migration of single receptor CCRI-HEK transfectants was also inhibited by the cosalanes. Acetylation of the reactive amino groups of RANTES abrogated the inhibitory activity of cosalane. The data suggest that cosalane and its structural analogues may interfere with the RANTES/CCR1 interaction by binding to RANTES.
Cancer Research | 1999
Michael Dean; Lisa P. Jacobson; Glen McFarlane; Joseph B. Margolick; Frank J. Jenkins; O. M. Zack Howard; Hui Fang Dong; James J. Goedert; Susan Buchbinder; Edward D. Gomperts; David Vlahov; Joost J. Oppenheim; Stephen J. O'Brien; Mary Carrington
Blood | 2005
O. M. Zack Howard; Hui Fang Dong; Shao Bo Su; Rachel R. Caspi; Xin Chen; Paul H. Plotz; Joost J. Oppenheim
Clinical Cancer Research | 2002
Gregory P. Schneider; Rosalba Salcedo; Hui Fang Dong; Hynda K. Kleinman; Joost J. Oppenheim; O.M. Howard
Cellular Immunology | 2004
Il Yup Chung; Hui Fang Dong; Xia Zhang; Nahed M.A. Hassanein; O. M. Zack Howard; Joost J. Oppenheim; Xin Chen
Archive | 2013
O M Howard; Hui Fang Dong; Shao Bo Su; Rachel R. Caspi; Xin Chen; Paul H. Plotz; Joost J